Back to Clinical Trials
Phase 3Starting soon

Morphine or Ketamine for Analgesia

Sponsored by Columbia University

About this study

Pain is common in children presenting to the emergency department but is frequently undertreated, leading to both short- and long-term consequences. Morphine is the standard treatment for children with moderate to severe acute pain, but its use is associated with serious side effects and caregiver and clinician concerns related to opioid administration. The investigators aim to determine if sub-dissociative ketamine is non-inferior to morphine for treating acute pain and a preferable alternative for treating acute pain in children because of its more favorable side effect profile and potential long-term benefits related to pain-related function, analgesic use/misuse, and mental and behavioral health outcomes.

Aim 1: To determine if IV sub-dissociative ketamine is non-inferior to IV morphine for decreasing pain intensity in children presenting to an ED with acute pain. The investigators hypothesize that IV sub-dissociative ketamine is non-inferior to IV morphine for decreasing pain intensity in children with acute abdominal pain or an extremity fracture. Aim 2: To compare the rate of acute (\<2 hours) adverse events, including cardiopulmonary adverse events, associated with IV sub-dissociative ketamine and IV morphine. The investigators hypothesize that there is a smaller proportion of cardiopulmonary adverse events associated with IV sub-dissociative ketamine compared to IV morphine. Aim 3: To determine the relationship between ketamine and long-term sequelae of acute pain. The investigators …

Where this study is enrolling (8)

Show all 8 locations
Who can participate

Inclusion criteria

  • ✓1. Abdominal pain or isolated long-bone extremity fracture (suspected or proven)
  • ✓2. Self-reported pain score of ≥ 6/10
  • ✓3. Requires IV morphine for analgesia as determined by the treating physician

Exclusion criteria

  • ✕1. Weight \> 82.4 kg
  • ✕2. Known allergy/contraindication to morphine or ketamine
  • ✕3. Antecedent receipt of ketamine related to presenting complaint
  • ✕4. Inability to use self-report measures of pain or questionnaires
  • ✕5. Chronic disease associated with pain
  • ✕6. Chronic pain condition requiring use of opioids as outpatient
  • ✕7. Hemodynamic instability or critical illness per treating physician
  • ✕8. Altered mental state (e.g., GCS , 14 or clinical intoxication)
  • ✕9. Known history of schizophrenia, liver or kidney problems, or osteogenesis imperfecta
  • ✕10. Concern for open fracture, neurovascular compromise, or compartment syndrome
  • ✕11. Injuries in addition to the extremity injury (e.g., head, neck, abdomen)
  • ✕12. Known or reported pregnancy
  • ✕13. Does not speak English or Spanish
  • ✕14. Patient previously enrolled in this study
  • ✕15. Wards of state, foster children, or children in custody

Only the research team can confirm whether you qualify. The intake questionnaire is the best way to find out.

Completing a questionnaire on Clinably does not enroll you in a clinical trial or confirm your eligibility. Only the research team can determine whether you qualify to participate. These results are based on the information you provide and are intended to help you start a conversation with the research team.

Trial data sourced from ClinicalTrials.gov.